Cargando…

Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases

Lung diseases are described by a wide variety of developmental mechanisms and clinical manifestations. Accurate classification and diagnosis of lung diseases are the bases for development of effective treatments. While extensive studies are conducted toward characterization of various lung diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Arakelyan, Arsen, Nersisyan, Lilit, Petrek, Martin, Löffler-Wirth, Henry, Binder, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859092/
https://www.ncbi.nlm.nih.gov/pubmed/27200087
http://dx.doi.org/10.3389/fgene.2016.00079
_version_ 1782430909499179008
author Arakelyan, Arsen
Nersisyan, Lilit
Petrek, Martin
Löffler-Wirth, Henry
Binder, Hans
author_facet Arakelyan, Arsen
Nersisyan, Lilit
Petrek, Martin
Löffler-Wirth, Henry
Binder, Hans
author_sort Arakelyan, Arsen
collection PubMed
description Lung diseases are described by a wide variety of developmental mechanisms and clinical manifestations. Accurate classification and diagnosis of lung diseases are the bases for development of effective treatments. While extensive studies are conducted toward characterization of various lung diseases at molecular level, no systematic approach has been developed so far. Here we have applied a methodology for pathway-centered mining of high throughput gene expression data to describe a wide range of lung diseases in the light of shared and specific pathway activity profiles. We have applied an algorithm combining a Pathway Signal Flow (PSF) algorithm for estimation of pathway activity deregulation states in lung diseases and malignancies, and a Self Organizing Maps algorithm for classification and clustering of the pathway activity profiles. The analysis results allowed clearly distinguish between cancer and non-cancer lung diseases. Lung cancers were characterized by pathways implicated in cell proliferation, metabolism, while non-malignant lung diseases were characterized by deregulations in pathways involved in immune/inflammatory response and fibrotic tissue remodeling. In contrast to lung malignancies, chronic lung diseases had relatively heterogeneous pathway deregulation profiles. We identified three groups of interstitial lung diseases and showed that the development of characteristic pathological processes, such as fibrosis, can be initiated by deregulations in different signaling pathways. In conclusion, this paper describes the pathobiology of lung diseases from systems viewpoint using pathway centered high-dimensional data mining approach. Our results contribute largely to current understanding of pathological events in lung cancers and non-malignant lung diseases. Moreover, this paper provides new insight into molecular mechanisms of a number of interstitial lung diseases that have been studied to a lesser extent.
format Online
Article
Text
id pubmed-4859092
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48590922016-05-19 Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases Arakelyan, Arsen Nersisyan, Lilit Petrek, Martin Löffler-Wirth, Henry Binder, Hans Front Genet Genetics Lung diseases are described by a wide variety of developmental mechanisms and clinical manifestations. Accurate classification and diagnosis of lung diseases are the bases for development of effective treatments. While extensive studies are conducted toward characterization of various lung diseases at molecular level, no systematic approach has been developed so far. Here we have applied a methodology for pathway-centered mining of high throughput gene expression data to describe a wide range of lung diseases in the light of shared and specific pathway activity profiles. We have applied an algorithm combining a Pathway Signal Flow (PSF) algorithm for estimation of pathway activity deregulation states in lung diseases and malignancies, and a Self Organizing Maps algorithm for classification and clustering of the pathway activity profiles. The analysis results allowed clearly distinguish between cancer and non-cancer lung diseases. Lung cancers were characterized by pathways implicated in cell proliferation, metabolism, while non-malignant lung diseases were characterized by deregulations in pathways involved in immune/inflammatory response and fibrotic tissue remodeling. In contrast to lung malignancies, chronic lung diseases had relatively heterogeneous pathway deregulation profiles. We identified three groups of interstitial lung diseases and showed that the development of characteristic pathological processes, such as fibrosis, can be initiated by deregulations in different signaling pathways. In conclusion, this paper describes the pathobiology of lung diseases from systems viewpoint using pathway centered high-dimensional data mining approach. Our results contribute largely to current understanding of pathological events in lung cancers and non-malignant lung diseases. Moreover, this paper provides new insight into molecular mechanisms of a number of interstitial lung diseases that have been studied to a lesser extent. Frontiers Media S.A. 2016-05-06 /pmc/articles/PMC4859092/ /pubmed/27200087 http://dx.doi.org/10.3389/fgene.2016.00079 Text en Copyright © 2016 Arakelyan, Nersisyan, Petrek, Löffler-Wirth and Binder. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Arakelyan, Arsen
Nersisyan, Lilit
Petrek, Martin
Löffler-Wirth, Henry
Binder, Hans
Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases
title Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases
title_full Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases
title_fullStr Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases
title_full_unstemmed Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases
title_short Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases
title_sort cartography of pathway signal perturbations identifies distinct molecular pathomechanisms in malignant and chronic lung diseases
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859092/
https://www.ncbi.nlm.nih.gov/pubmed/27200087
http://dx.doi.org/10.3389/fgene.2016.00079
work_keys_str_mv AT arakelyanarsen cartographyofpathwaysignalperturbationsidentifiesdistinctmolecularpathomechanismsinmalignantandchroniclungdiseases
AT nersisyanlilit cartographyofpathwaysignalperturbationsidentifiesdistinctmolecularpathomechanismsinmalignantandchroniclungdiseases
AT petrekmartin cartographyofpathwaysignalperturbationsidentifiesdistinctmolecularpathomechanismsinmalignantandchroniclungdiseases
AT lofflerwirthhenry cartographyofpathwaysignalperturbationsidentifiesdistinctmolecularpathomechanismsinmalignantandchroniclungdiseases
AT binderhans cartographyofpathwaysignalperturbationsidentifiesdistinctmolecularpathomechanismsinmalignantandchroniclungdiseases